New platform aims to better characterize tumor cell populations that survive therapy and drive cancer relapseDALLAS--(BUSINESS WIRE)--SingleCell Biotechnology, a biotechnology company developing ...

Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA ...

Seattle’s life sciences cluster refused to cool off in 2025. Two major lab towers came online, and a run of sizeable leases from research institutions and growing biotech firms helped soak up much of ...

The new facial care range combines Swiss laboratory development, green biotechnology, and high percentages of natural-origin ingredients, according to the company.

Plastic waste is becoming an increasing problem, with 50 million tonnes of single-use plastic being produced each year. Plastics are used in the packaging of food and drinks.

Pakistani student Muhammad Jalal (right) works in a laboratory at Anhui Agricultural University in Hefei, Anhui province, on March 9. [Photo/Xinhua] HEFEI — Almost every morning, Muhammad Jalal finds ...

Collaboration to Deliver Superconducting Magnets up to 30 Tesla Through this partnership with the MagLab, Quantum ...

Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming ...

A London-based biotech start-up is accelerating its growth after securing investment to advance artificial intelligence-driven drug discovery technology. Ternary Therapeutics has… | Health | London | ...

St. Jude interns share experiences in GMP manufacturing, highlighting SOPs, aseptic techniques, and collaboration in advancing pediatric care.

Actorius Innovations and Research Pvt Ltd, a Indo-US biotechnology company, has been working to revolutionize oncology through advanced circulating tumor cell (CTC) technologies, and continues to make ...

Sartorius Stedim Biotech, which reported 2025 sales revenue of around €3 billion, set a narrower organic growth target of 9% to 12% per year, with EBITDA margin expansion of 60 to 85 basis points ...